COSTA, CLAUDIA

COSTA, CLAUDIA  

Mostra records
Risultati 1 - 20 di 59 (tempo di esecuzione: 0.024 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
BRIT‐1 expression and its relationship with PARP‐1 and CAF‐1/p60 in cutaneous melanoma 1.1 Articolo in rivista 2021 Russo, Daniela; Travaglino, Antonio; Varricchio, Silvia; Merolla, Francesco; Ilardi, Gennaro; Raffone, Antonio; Scalvenzi, Massimiliano; Costa, Claudia; Fabbrocini, Gabriella; Staibano, Stefania; Mascolo, Massimo
Tissue Expression of Carbonic Anhydrase IX Correlates to More Aggressive Phenotype of Basal Cell Carcinoma 1.1 Articolo in rivista 2021 Russo, Daniela; Varricchio, Silvia; Ilardi, Gennaro; Martino, Francesco; Di Crescenzo, Rosa Maria; Pignatiello, Sara; Scalvenzi, Massimiliano; Costa, Claudia; Mascolo, Massimo; Merolla, Francesco; Staibano, Stefania
Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt 1.1 Articolo in rivista 2020 Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M.
Drug holiday regimen for vismodegib treatment in patients with multiple primary basal cell carcinomas 1.1 Articolo in rivista 2020 Villani, A.; Costa, C.; Fabbrocini, G.; Scalvenzi, M.
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004–2018 1.1 Articolo in rivista 2020 Villani, A.; Costa, C.; Fabbrocini, G.; Cinelli, E.; Greco, V.; Scalvenzi, M.
Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single-centre retrospective study 1.1 Articolo in rivista 2021 Villani, A.; Fabbrocini, G.; Costa, C.; Cappello, M.; Scalvenzi, M.
Hair Loss in Patients Treated with Vismodegib: A Single-Center Retrospective Study 1.1 Articolo in rivista 2020 Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M.
Dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor sonidegib to manage adverse effects: A retrospective case series 1.1 Articolo in rivista 2021 Villani, Alessia; Costa, Claudia; Fabbrocini, Gabriella; Ruggiero, Angelo; Scalvenzi, Massimiliano
Awareness on sun protection behavior among melanoma and nonmelanoma skin cancer patients: An Italian tertiary cancer center experience 1.1 Articolo in rivista 2021 Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M.
Response to "Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT) trial at 42 months" 1.1 Articolo in rivista 2021 Villani, Alessia; Fabbrocini, Gabriella; Costa, Claudia; Scalvenzi, Massimiliano
Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies 1.1 Articolo in rivista 2019 Villani, Alessia; Fabbrocini, Gabriella; Costa, Claudia; Carmela Annunziata, Maria; Scalvenzi, Massimiliano
Dermoscopic patterns of intradermal naevi 1.1 Articolo in rivista 2020 Greco, Vincenzo; Cappello, Milena; Megna, Matteo; Costa, Claudia; Villani, Alessia; Fabbrocini, Gabriella; Marino, Vincenzo; Scalvenzi, Massimiliano
A rare evolution of porokeratosis 1.1 Articolo in rivista 2020 Mascolo, Massimo; Patrì, Angela; Pace, Mirella; Costa, Claudia; Varricchio, Silvia; Travaglino, Antonio; Scalvenzi, Massimiliano
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic 1.1 Articolo in rivista 2020 Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M.
Comment on: “Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring” 1.1 Articolo in rivista 2020 Villani, A.; Fabbrocini, G.; Greco, V.; Costa, C.; Scalvenzi, M.
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity 1.1 Articolo in rivista 2020 Scalvenzi, M.; Cappello, M.; Costa, C.; Fabbrocini, G.; Luciano, M.; Villani, A.
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment 1.1 Articolo in rivista 2020 Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M.
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma 1.1 Articolo in rivista 2020 Villani, A.; Fabbrocini, G.; Costa, C.; Scalvenzi, M.
Second primary melanoma: incidence rate and risk factors 1.1 Articolo in rivista 2020 Villani, A.; Fabbrocini, G.; Costa, C.; Greco, V.; Scalvenzi, M.
The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients 1.1 Articolo in rivista 2020 Villani, A; Costa, C; Cappello, M; Fabbrocini, G; Scalvenzi, M